The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPirogov Russian National Research Medical University
About this trial
Technically successful laser crossectomy will reduce the risk of reflux recurrence at the sapheno-femoral junction without increasing the risk of endovenous heat-induced thrombosis, which may positively impact the likelihood of ultrasound- or clinical-recurrence of varicose veins. Similar technical efficacy is expected for laser crossectomy at 1940 nm and 1470 nm. A possible advantage of the 1940 nm wavelength in terms of postoperative pain intensity and the risk of adverse events cannot be ruled out.
Eligibility criteria
Qualifiers
Age >18 years
Primary VVs of Clinical Etiology Anatomy Pathophysiology (CEAP) clinical class of C2-C6
Reflux along the GSV trunk lasting >0.5 sec.
GSV trunk diameter ≤12 mm
Disqualifiers
Primary reflux outside the GSV trunk (including combined reflux)
History of deep or superficial vein thrombosis
Deep vein reflux
Non-thrombotic or post-thrombotic venous obstruction
Trial design
Treatments tested in this trial
- Laser crossectomy on 1470 nm
- Laser crossectomy on 1940 nm
- Standard EVLT with a stump
Treatment groups
400 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov